Clinical Trial Update: Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 safety and pharmacokinetics study of PF-04287881 in healthy adults, with the condition focus listed as Respiratory Tract Infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections

Drugs mentioned

• PF-04287881

Snippet

Sponsor: Pfizer | Conditions: Respiratory Tract Infections | Phase 1 | Status: COMPLETED